Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atlantic Equities Maintains Neutral on AbbVie, Lowers Price Target to $154

Atlantic Equities analyst Steve Chesney maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $157 to $154.

byBenzinga Newsdesk

February 10, 2023

1 minute read

Atlantic Equities analyst Steve Chesney maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $157 to $154.

Evercore ISI Group Downgrades LivePerson to In-Line, Lowers Price Target to $20

By Benzinga Newsdesk

February 25, 7:18 AM

Evercore ISI Group analyst Peter Levine downgrades LivePerson (NASDAQ:LPSN) from Outperform to In-Line and lowers the price target from $75 to $20.

LPSN

News

Google Canada Says Signed Agreements With Canadian Publishers for Google News Showcase

By Charles Gross

June 24, 5:23 AM

https://canada.googleblog.com/

GOOG

$1000 Invested In Alphabet 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights

November 4, 11:41 AM

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 10 years by 7.39% on an annualized basis producing an average annual return of 17.99%. Currently, Alphabet has a market capitalization of $1.12 trillion.

GOOGL

54 Biggest Movers From Yesterday

By Lisa Levin

April 20, 5:43 AM

Gainers

ACC

Atlantic Equities Maintains Neutral on AbbVie, Lowers Price Target to $154

Related Posts

Evercore ISI Group Downgrades LivePerson to In-Line, Lowers Price Target to $20

Google Canada Says Signed Agreements With Canadian Publishers for Google News Showcase

$1000 Invested In Alphabet 10 Years Ago Would Be Worth This Much Today

54 Biggest Movers From Yesterday